menu ☰
menu ˟

Phase 3 DAA trials do not reflect wider HIV/HCV population

20 Jan 2016
Many recent phase 3 clinical trials supporting direct-acting antiviral therapy for patients with HIV/hepatitis C virus coinfection mandated strict eligibility criteria for their participants and may not be an accurate representation of the general po...

Click here to view the full article which appeared in Hepatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.